1. Volume 66, Issue 2, Pages 275-281 (August 2014)
Temsirolimus in Daily Use: Results of a Prospective Multicentre Noninterventional Study of Patients with Metastatic Kidney Cancer 
Andres Jan Schrader, Sandra Seseke, Christian Keil, Edwin Herrmann, Peter J. Goebell, Steffen Weikert, Sandra Steffens, Lothar Bergmann, Jan Roigas, Thomas Steiner 
European Urology 
Volume 66, Issue 2, Pages (August 2014)
DOI: /j.eururo
Copyright © 2013 European Association of Urology Terms and Conditions

2. Fig. 1
(a) Progression-free survival (PFS) and (b) overall survival (OS) for 386 evaluable patients receiving temsirolimus during the STARTOR trial plotted against the line of treatment (Kaplan-Meier). Neither the median PFS (5.3 vs 4.5 mo; p=0.27, log rank) nor the OS (10.5 vs 13.7 mo; p=0.62, log rank) differed significantly between patients without (n=162) and with (n=224) prior systemic therapy.
European Urology  , DOI: ( /j.eururo )
Copyright © 2013 European Association of Urology Terms and Conditions

3. Fig. 2
(a) Progression-free survival (PFS) and (b) overall survival (OS) for 386 evaluable patients receiving temsirolimus during the STARTOR trial plotted against the histologic renal cell carcinoma (RCC) subtype (Kaplan-Meier). Neither the median PFS (5.1 vs 4.2 mo; p=0.32, log rank) nor the OS (12.6 vs 11.0 mo; p=0.28, log rank) differed significantly between patients with clear cell RCC (ccRCC) (n=297) and non-ccRCC or undefined RCC (n=89).
European Urology  , DOI: ( /j.eururo )
Copyright © 2013 European Association of Urology Terms and Conditions

4. Fig. 3
(a) Progression-free survival (PFS) and (b) overall survival (OS) for 386 evaluable patients receiving temsirolimus during the STARTOR trial plotted against the patient's age (Kaplan-Meier). Neither the median PFS (4.5 vs 5.1 mo; p=0.17, log rank) nor the OS (10.5 vs 13.5 mo; p=0.45, log rank) differed significantly between patients <65 yr of age (n=149) and ≥65 yr of age (n=237).
European Urology  , DOI: ( /j.eururo )
Copyright © 2013 European Association of Urology Terms and Conditions